Expo
view channel
view channel
view channel
view channel
view channel
view channel
view channel
view channel
view channel
Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry
Events
Webinars
- New Biomarker Recommendations Aim to Personalize Stroke Rehabilitation
- NIH-Funded Study Targets Saliva-Based Long COVID Diagnosis
- Validated Biomarker Blood Test Detects Early Lung Cancer and Supports Risk Assessment
- Machine Learning Model Uses Routine Lab Tests to Support Heart Failure Classification
- Multiprotein Plasma Panel Identifies Remission in Vasculitis
- Urine Genomic Test Detects More Than Nine in Ten Suspected Bladder Cancers
- Liquid Biopsy Test Predicts Tissue of Origin in Cancer of Unknown Primary
- Study Identifies Genetic Marker Missing from Common Pharmacogenomic Panels
- Single-Tube CRISPR Test Detects Pathogens and Genetic Variants in 30 Minutes
- New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients
- Ultra-Portable Device Enables Finger-Prick Blood Testing at Home
- Age-Specific CBC Reference Intervals Support Pediatric Diagnosis in Vietnam
- Spectral Flow Cytometry Assay Enhances MRD Detection in Multiple Myeloma
- New Marker Helps Detect Aggressive Multiple Myeloma Earlier
- New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer
- Temporal Immune Profiling Reveals How Sepsis States Change Over Time
- Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID-19
- Gut “Memory” May Explain Why IBD Flares Return
- AI-Based Antibody Profiling Predicts Strength of COVID-19 Vaccine Response
- Immune Biomarkers May Predict Recurrent Checkpoint Inhibitor Arthritis
- New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours
- Genetic Marker Identifies Emerging Resistance to Frontline Malaria Drugs
- Surveillance and Susceptibility Testing Track Rising Candida Auris in U.S.
- Plasma Cell-Free DNA Test Enables Earlier Diagnosis of Invasive Fungal Infections
- FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection
- Autonomous Robotic System Receives FDA Authorization for Blood Collection
- Interoperable Data Platform Standardizes Multi-Cancer Blood Test Results
- Training Device Improves Accuracy of Pooled Molecular Diagnostics
- New CE-Certified Software Advances Whole-Genome Cancer Testing
- National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
- Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
- Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
- Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring
- Companion Diagnostics Expand HER2 Testing in Metastatic Gastroesophageal Cancer
- Global Urinalysis Market Gowth Driven by Demand for Automated and POC Testing
- Blood Metabolite Signature Predicts ALS Progression and Points to Treatment Strategy
- Computational Tool Identifies Central Asthma Genes for Target Discovery
- Age-Related Genomic Differences Could Refine Treatment Decisions in Lung Cancer
- Molecular Pathway Reveals Driver of Triple-Negative Breast Cancer Spread
- D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
- AI Tool Improves Prediction of Immunotherapy Response in Lung Cancer
- New Journal Addresses Evolving Needs in Clinical and Translational Pathology
- AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells
- AI-Pathologist Framework Improves Accuracy and Reliability in Cancer Diagnosis
- New Review Highlights Intelligent Agents as Next Step for Digital Pathology
Expo
- New Biomarker Recommendations Aim to Personalize Stroke Rehabilitation
- NIH-Funded Study Targets Saliva-Based Long COVID Diagnosis
- Validated Biomarker Blood Test Detects Early Lung Cancer and Supports Risk Assessment
- Machine Learning Model Uses Routine Lab Tests to Support Heart Failure Classification
- Multiprotein Plasma Panel Identifies Remission in Vasculitis
- Urine Genomic Test Detects More Than Nine in Ten Suspected Bladder Cancers
- Liquid Biopsy Test Predicts Tissue of Origin in Cancer of Unknown Primary
- Study Identifies Genetic Marker Missing from Common Pharmacogenomic Panels
- Single-Tube CRISPR Test Detects Pathogens and Genetic Variants in 30 Minutes
- New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients
- Ultra-Portable Device Enables Finger-Prick Blood Testing at Home
- Age-Specific CBC Reference Intervals Support Pediatric Diagnosis in Vietnam
- Spectral Flow Cytometry Assay Enhances MRD Detection in Multiple Myeloma
- New Marker Helps Detect Aggressive Multiple Myeloma Earlier
- New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer
- Temporal Immune Profiling Reveals How Sepsis States Change Over Time
- Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID-19
- Gut “Memory” May Explain Why IBD Flares Return
- AI-Based Antibody Profiling Predicts Strength of COVID-19 Vaccine Response
- Immune Biomarkers May Predict Recurrent Checkpoint Inhibitor Arthritis
- New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours
- Genetic Marker Identifies Emerging Resistance to Frontline Malaria Drugs
- Surveillance and Susceptibility Testing Track Rising Candida Auris in U.S.
- Plasma Cell-Free DNA Test Enables Earlier Diagnosis of Invasive Fungal Infections
- FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection
- Autonomous Robotic System Receives FDA Authorization for Blood Collection
- Interoperable Data Platform Standardizes Multi-Cancer Blood Test Results
- Training Device Improves Accuracy of Pooled Molecular Diagnostics
- New CE-Certified Software Advances Whole-Genome Cancer Testing
- National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
- Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
- Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
- Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring
- Companion Diagnostics Expand HER2 Testing in Metastatic Gastroesophageal Cancer
- Global Urinalysis Market Gowth Driven by Demand for Automated and POC Testing
- Blood Metabolite Signature Predicts ALS Progression and Points to Treatment Strategy
- Computational Tool Identifies Central Asthma Genes for Target Discovery
- Age-Related Genomic Differences Could Refine Treatment Decisions in Lung Cancer
- Molecular Pathway Reveals Driver of Triple-Negative Breast Cancer Spread
- D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
- AI Tool Improves Prediction of Immunotherapy Response in Lung Cancer
- New Journal Addresses Evolving Needs in Clinical and Translational Pathology
- AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells
- AI-Pathologist Framework Improves Accuracy and Reliability in Cancer Diagnosis
- New Review Highlights Intelligent Agents as Next Step for Digital Pathology
Client Login